CanadaBis Capital Inc. (TSXV:CANB.P) has launched its campaign on the Investing News Network’s cannabis channel.

CanadaBis Capital is a Canadian cannabis company developing a diverse business model built upon four main pillars: cultivation, research and product development, retail and hemp. The company aims to create a vertically-integrated model before it begins expansion throughout Canada. In order to drive its cultivation business, CanadaBis has acquired Stigma Grow, a cannabis cultivation company in development of a 66,000-square foot craft cannabis cultivation facility in Red Deer, Alberta.


Once construction of the first building is complete, Stigma Grow plans to add another 66,000-square foot facility directly adjacent to the first. This doubling of the company’s cultivation space is expected to increase Stigma Grow’s total production to 32,000 kilograms annually. Stigma Grow has also secured an additional 800,000 square feet of cultivation and processing space to be used in future cultivation operations. The company has developed 42 proprietary strains that have proven to be mold, mildew and pest resistant after three years of research and development.

CanadaBis Capital’s company highlights include the following:

  • Canadian cannabis market to generate up to $7.17 billion in sales in 2019.
  • Alberta’s recreational cannabis market to reach $1 billion per year.
  • Stigma Grow has a 66,000-square-foot craft cannabis cultivation facility in Red Deer, Alberta which is expected to produce up to 16,000 kilograms of cannabis annually with a gross margin of $84 million.
  • Developed 42 unique, proprietary strains that are mold, mildew and pest resistant.
  • Working to acquire a wholly-owned retail location in Red Deer’s “Gasoline Alley”.
  • Anticipated revenue generation of $9 million annually per retail store once Health Canada legalizes value-added products.
  • In discussions to acquire a cannabis R&D facility in Alberta.

Click here to see the educational profile for CanadaBis Capital Inc. (TSXV:CANB.P) and to request an investor presentation.

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less